Unithroid Misappropriated Trade Secrets Claims Against FDA Reinstated
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal appeals court rules Jerome Stevens properly alleged an independent injury resulting from FDA’s disclosure of trade secrets and confidential information relating to the Unithroid (levothyroxine) NDA.